Debra Hanks

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.2K citations · Full text

Cancer Immunosurveillance, Advanced Lung Disease, Medicine +8

Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer

Karina Kulangara, Nancy R. Zhang, Ellie Corigliano et al. · Archives of Pathology & Laboratory Medicine · 2018 · 514 citations · Full text

Development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors with the immunohistochemistry assay PD-L1 IHC 22C3 pharmDx.

Karina Kulangara, Debra Hanks, Stephanie Waldroup et al. · Journal of Clinical Oncology · 2017 · 87 citations

Solid Tumors, Combined Positive Score, Immunodeficiencies +22

Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images

Apaar Sadhwani, Huang-Wei Chang, Ali Behrooz et al. · Scientific Reports · 2021 · 54 citations · Full text

Investigation of PD-L1 expression and response to pembrolizumab (pembro) in gastric cancer (GC) and cervical cancer (CC) using combined positive score (CPS) and tumor proportion score (TPS).

Karina Kulangara, Lindsay Guerrero, Alex Posch et al. · Journal of Clinical Oncology · 2018 · 21 citations

Inflammatory Lung Disease, Immunology, Immunoediting +18